Ligand Pharmaceuticals Incorporated
$5.40B- Market cap
- $5.76B
- Debt
- +$374.08M
- Cash
- −$733.52M
Capital structure 94% equity / 6% debt · EV / Revenue 20.14x · EV / EBITDA 33.68x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
LGND · price snapshotP/S 21.48x
$288.83Snapshot Sep 8, 2026, 4:00 PM ET
Implied fair value · at IART's multiple
$10.4096.4% below market
13.45 LGND revenue / share×0.77x IART P/S=$10.40
Market $288.83Implied $10.40
IART · price snapshotP/S 0.77x
$16.26Snapshot Sep 8, 2026, 4:00 PM ET
Implied fair value · at LGND's multiple
$451.602,677.4% above market
21.03 IART revenue / share×21.48x LGND P/S=$451.60
Market $16.26Implied $451.60